- Home
- SEMR vs GPCR Comparison
SEMR vs GPCR Comparison
Compare SEMR & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEMR
- GPCR
- Stock Information
- Founded
- SEMR 2008
- GPCR 2016
- Country
- SEMR United States
- GPCR United States
- Employees
- SEMR N/A
- GPCR N/A
- Industry
- SEMR EDP Services
- GPCR
- Sector
- SEMR Technology
- GPCR
- Exchange
- SEMR Nasdaq
- GPCR Nasdaq
- Market Cap
- SEMR 1.3B
- GPCR 1.1B
- IPO Year
- SEMR 2021
- GPCR 2023
- Fundamental
- Price
- SEMR $7.43
- GPCR $18.74
- Analyst Decision
- SEMR Buy
- GPCR Strong Buy
- Analyst Count
- SEMR 8
- GPCR 9
- Target Price
- SEMR $14.88
- GPCR $75.63
- AVG Volume (30 Days)
- SEMR 1.3M
- GPCR 888.0K
- Earning Date
- SEMR 08-04-2025
- GPCR 08-06-2025
- Dividend Yield
- SEMR N/A
- GPCR N/A
- EPS Growth
- SEMR N/A
- GPCR N/A
- EPS
- SEMR N/A
- GPCR N/A
- Revenue
- SEMR $413,962,000.00
- GPCR N/A
- Revenue This Year
- SEMR $21.85
- GPCR N/A
- Revenue Next Year
- SEMR $18.50
- GPCR N/A
- P/E Ratio
- SEMR N/A
- GPCR N/A
- Revenue Growth
- SEMR 22.16
- GPCR N/A
- 52 Week Low
- SEMR $7.01
- GPCR $13.22
- 52 Week High
- SEMR $18.74
- GPCR $45.37
- Technical
- Relative Strength Index (RSI)
- SEMR 37.09
- GPCR 54.21
- Support Level
- SEMR $7.01
- GPCR $15.80
- Resistance Level
- SEMR $7.83
- GPCR $17.81
- Average True Range (ATR)
- SEMR 0.44
- GPCR 0.95
- MACD
- SEMR -0.21
- GPCR 0.16
- Stochastic Oscillator
- SEMR 13.88
- GPCR 92.74
About SEMR SEMrush Holdings Inc.
SEMrush Holdings Inc is engaged in the online visibility management software-as-a-service (SaaS) platform. Its platform utilizes data and intelligence at the core surrounded by AI-powered interconnected hubs focused on search engine optimization, paid advertising, social media management, local marketing, brand marketing, and content marketing Geographically, it generates revenues from the United States, the UK, and Others.
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.